Search

Your search keyword '"Kukreti, Vishal"' showing total 932 results

Search Constraints

Start Over You searched for: Author "Kukreti, Vishal" Remove constraint Author: "Kukreti, Vishal" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
932 results on '"Kukreti, Vishal"'

Search Results

6. Canadian cancer trials group LY.17: A randomized phase II study evaluating novel salvage therapy pre‐autologous stem cell transplant in relapsed/refractory diffuse large B‐cell lymphoma—outcome of rituximab‐dose‐intensive cyclophosphamide, etoposide, cisplatin (R‐DICEP) versus R‐GDP

11. A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis.

15. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

23. Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma

24. Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma

27. Ambulatory Toxicity Management (AToM) Pilot: results of a pilot study of a pro-active, telephone-based intervention to improve toxicity management during chemotherapy for breast cancer

28. The I-Can Manage web-based cancer self-management program targeting treatment toxicities and health behaviours: Human centred co-design approach and cognitive-think aloud usability testing (Preprint)

29. Human centered co-design and usability testing of a web-based cancer self-management education program (I-Can Manage) targeting treatment toxicities and health behaviours (Preprint)

30. Chromosome 1q Abnormalities Are Not an Independent Predictor of Survival in Multiple Myeloma

32. Frailty in Patients Undergoing Chimeric Antigen Receptor T-Cell (CAR T) Therapy at Princess Margaret Cancer Centre: A Prospective Pilot Study

33. Correlation Amongst Scoring of Various Frailty Tools in Myeloma Patients Undergoing Autologous Stem Cell Transplantation

34. Crebbp Mutations Are Associated with Shorter Time to Progression in Limited-Stage Follicular Lymphoma Treated with Radiation

35. Five hematologic tests and treatments to question

37. From Choosing Wisely to Implementing Wisely in Cancer Care: A Scoping Review

39. Clinical significance of clonal hematopoiesis in the setting of autologous stem cell transplantation for lymphoma

45. A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

46. An open-label, single-arm, phase 2 (PX-171-004) study of single-agent carfilzomib in bortezomib-naive patients with relapsed and/or refractory multiple myeloma

48. Publisher Correction: The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

49. Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume

Catalog

Books, media, physical & digital resources